Updated Jul 16, 2026
Daly James M has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.

James M. Daly is a corporate director involved with several biopharmaceutical companies, including Acadia Pharmaceuticals Inc. He has held directorial roles at Cytokinetics Inc, Acadia Pharmaceuticals, and Madrigal Pharmaceuticals, contributing to the governance of these firms.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 454 | $0.00 | |
| 2026-06-01 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 8.1K | — | |
| 2026-05-27 | CYTK | CYTOKINETICS INC | A — Grant or award | 2.9K | $0.00 | |
| 2026-04-15 | CYTK | CYTOKINETICS INC | A — Grant or award | 191 | $65.37 | $12K |
| 2026-01-20 | CYTK | CYTOKINETICS INC | A — Grant or award | 197 | $63.44 | $12K |
| 2025-06-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 715 | $0.00 | |
| 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 9.4K | — |
James M. Daly is a corporate director involved with several biopharmaceutical companies, including Acadia Pharmaceuticals Inc. He has held directorial roles at Cytokinetics Inc, Acadia Pharmaceuticals, and Madrigal Pharmaceuticals, contributing to the governance of these firms.…
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Daly James M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.